Cancer Immunotherapy Explained: PD-1, PD-L1, CTLA-4, Checkpoint Inhibitors and Immune Side Effects | Immunotherapy Using Checkpoint Inhibitors

This oncology lesson details Immunotherapy Using Checkpoint Inhibitors with a focused overview of cancer immunotherapy, immune checkpoint inhibitors, and PD-1 PD-L1 blockade. The presentation connects CTLA-4 inhibitors, immune related adverse events, and immuno-oncology, with practical context for diagnosis, treatment sequencing, expected outcomes, and follow-up. The video is especially relevant to people searching for cancer immunotherapy, CTLA-4 inhibitors, or immune related adverse events and wanting a clearer explanation of how oncologists make treatment decisions. Useful for learning how modern cancer care combines imaging, pathology, systemic therapy, surgery, radiation, and supportive care. Treatment plans vary with stage pathology molecular features prior therapy